Instrument Inactif

Communiqués Invitae Corporation

Actions

NVTA.Q

US46185L1035

Recherche biotechnologique et médicale

Communiqués

30/10/24	DELFI Diagnostics Names Robert Guigley as Chief Commercial Officer to Expand Access to Early Cancer Screening	AQ
08/08/24	Invitae : Bankruptcy Form 8 K	PU
01/07/24	Invitae : Regulation FD Presentation Form 8 K	PU
07/03/24	Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results	AQ
14/02/24	Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process	PR
15/12/23	Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO	AQ
13/12/23	Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts	PR
16/11/23	Aranscia Acquires YouScript from Invitae	AQ
08/11/23	Invitae: Q3 Earnings Snapshot	AQ
08/11/23	Invitae Reports Third Quarter 2023 Financial Results	PR
06/11/23	Invitae Launches Enhanced Chemistry of MRD Test to Better Serve Biopharmaceutical Clinical and Research Partnerships	PR
01/11/23	Invitae to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023	PR
19/10/23	Invitae Appoints Dr. David Sholehvar as Chief Operating Officer	PR
10/10/23	Invitae to Present Data at the National Society of Genetic Counselors 42nd Annual Conference That Supports Advancements in Medical Genomics	PR
03/10/23	Invitae's Common Hereditary Cancers Panel Receives FDA Market Authorization	PR
02/10/23	FDA Grants First Marketing Authorization for a DNA Test to Assess Predisposition for Dozens of Cancer Types	AQ
25/09/23	Invitae Announces Appointment of Finance Veteran Ana Schrank as CFO	PR
25/09/23	Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard	AQ
22/09/23	Invitae Receives Notice of Non-Compliance with NYSE Minimum Share Price Continued Listing Standard	PR
28/08/23	Invitae Hires Industry Veteran Robert Guigley as Chief Commercial Officer	PR
16/08/23	Invitae - Clinical Trial Results Support Genetic Testing of All Patients with Prostate Cancer	AQ
14/08/23	Invitae Announces Selection of Finance Executive Robert Dickey as Interim CFO	PR
08/08/23	Invitae: Q2 Earnings Snapshot	AQ
08/08/23	Invitae Reports Second Quarter 2023 Financial Results	PR
26/07/23	Invitae to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023	PR